… We augment evidence on the impact of payment reform for Part B drugs and provider response
to financial incentives through a study of end-of-life chemotherapy treatment. We expand …

The management of terminal illnesses and the dying process is the source of considerable
dissatisfaction among growing numbers of Americans, as this issue of Generations so well …

… the context of end-of-life and palliative care, … end-of-life care than in other areas of medicine.
Here we discuss barriers to developing high quality, cost effective, and beneficial end-of-life …

… the end of life “Our culture emphasizes extending life, rather than comfort and quality of life.”
… A lack of payment and reimbursement for services at the end of life including physician and …

… Payment reform will be disruptive to all. Oncology must be engaged in policy discussions and
guide rational shifts in priorities defined by new payment … ASCO's Payment Reform Series …

… end-of-life reforms,70 other experts suggest that perhaps some association does exist between
end-of-life consultations and end-of-life … in the final week of life for patients with advanced …

… Part I provides a brief discussion of the legal and policy issues surrounding end-of-life care
… end-of-life care. In Part III, we discuss whether the utilization of palliative care at the end of life …

… end of life and how that payment system affects the timing of some patients' initial access to
hospice care. Next, it will laud Congress for using health care reform to change that payment …

… payment system on potential disparities in the use of PD. We hypothesize that the payment
reform … In studying the effects of the payment reform, we focused on factors previously found …

… end-of-life cohorts, did not alter complications, but did reduce the odds of dying by 6 percent.
This suggests that payment reform … about the value of payment reforms that seek to reduce …